Browse

Loss of PTEN Expression is an Independent Poor Prognostic Factor in Non-Small Cell Lung Cancer

DC Field Value Language
dc.contributor.authorYoo, Seol Bong-
dc.contributor.authorChoe, Gheeyoung-
dc.contributor.authorXu, Xianhua-
dc.contributor.authorLee, Hyunju-
dc.contributor.authorLee, Choon-Taek-
dc.contributor.authorChung, Jin-Haeng-
dc.contributor.authorJheon, Sanghoon-
dc.date.accessioned2012-06-28T05:39:43Z-
dc.date.available2012-06-28T05:39:43Z-
dc.date.issued2010-12-
dc.identifier.citationJOURNAL OF THORACIC ONCOLOGY; Vol.5 12; S392-S392ko_KR
dc.identifier.issn1556-0864-
dc.identifier.urihttps://hdl.handle.net/10371/77764-
dc.description.abstractIntroduction: The PTEN gene acts as a tumor suppressor gene and there are
various mechanisms involved to suppress its function, including mutation,
homozygous deletion, and promoter methylation. Recently, the role of PTEN
loss is focused on drug resistance mechanism, such as gefitinib. We investigated
PTEN protein expression in non-small cell lung cancer (NSCLC) and
correlated with clinicopathologic features to evaluate prognostic significance.
ko_KR
dc.language.isoenko_KR
dc.publisherLIPPINCOTT WILLIAMS & WILKINSko_KR
dc.titleLoss of PTEN Expression is an Independent Poor Prognostic Factor in Non-Small Cell Lung Cancerko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor우설봉-
dc.contributor.AlternativeAuthor최기영-
dc.contributor.AlternativeAuthor이현주-
dc.contributor.AlternativeAuthor전상훈-
dc.contributor.AlternativeAuthor이춘택-
dc.contributor.AlternativeAuthor정진행-
dc.citation.journaltitleJOURNAL OF THORACIC ONCOLOGY-
dc.description.tc0-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Pathology (병리학전공)Journal Papers (저널논문_병리학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse